Big thinking and bold ideas, the next phase of the SoM Research Roadmap

road3Year-end Blueprint report highlights accomplishments, goals for this year

“We have to think big. Now is the time to be bold with our ideas.”

That key message was one of several that Mary Stenzel-Poore, Ph.D., senior associate dean for research, impressed upon faculty research leaders at the kickoff to the academic year and launch of the next phase of the School of Medicine Research Roadmap.

The Research Roadmap is a strategic framework to guide the organization and administration of research, and to strategically guide the allocation of School of Medicine resources over the next five years. It was developed by more than 80 faculty research leaders in the school who together comprise the Collaborative Research Leadership Group (CRLG).

Presenting at the Oct. 8 CRLG meeting, Dr. Stenzel-Poore reported on roadmap progress and goals for the coming year.

As reported earlier, one of the biggest accomplishments during the roadmap’s “Blueprint Development” phase, which took place in 2011-2012, was establishment and launch of the Council for Research Opportunities and Strategies (CROS). The CROS had its first meeting in June.

Other accomplishments include the allocation of pilot funds to support novel, collaborative, multidisciplinary studies, revised Promotion and Tenure guidelines and increased biostatistical support for individual researchers.

Additional initiatives in progress include

  • Development of a new program in Complex Quantitative Biosciences
  • Analysis of barriers to faculty support in technology transfer and business development
  • Creation of data-driven methods to ascertain research strengths, opportunities and needs including a faculty needs assessment and a dedicated position to support the process
  • Creation of a Research Communication Committee to develop a strategic plan for coordinated and enhanced research communications

The Blueprint Development phase also featured several financial investments, among them an investment of about $236,000 in emergent program support and about $210,000 in biostatistical support. (See slide 8 for complete summary of roadmap investments.)

This coming year, 2012-2013, the roadmap moves into the “Blueprint Implementation” phase. “This past year we spent ‘cleaning up,’ so to speak, and we accomplished wonderful things, but now we have an opportunity to keep the momentum going and think big,” said Dr. Stenzel-Poore. “We want to gather all your big ideas so we can assess where we should be putting our energy. For example, what are the strengths we’re well-positioned for?”

That big theme along with addressing disparities in research, aligning clinical and basic research priorities and developing department strategic plans, will be major focal points throughout the coming year.

“The Blueprint is a living process, and it will change depending on our needs,” said Dean Mark Richardson. “It’s been a great process. In fact, we’ll be using the Research Roadmap to help guide a strategic planning process within our educational mission.”

Read the entire FY12 Blueprint Progress Report on SoM Research Voice (OHSU login required).